ASSEMBLY BIOSCIENCES, INC. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Assembly Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • Assembly Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $797K, a 29.8% decline year-over-year.
  • Assembly Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $3.33M, a 46.1% decline year-over-year.
  • Assembly Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.12M, a 22.4% decline from 2022.
  • Assembly Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.59M, a 25.9% increase from 2021.
  • Assembly Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.24M, a 76% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.12M -$1.47M -22.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $6.59M +$1.36M +25.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $5.24M -$16.6M -76% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $21.9M +$1.3M +6.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $20.6M -$7.93M -27.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 $28.5M +$19.9M +231% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $8.6M +$3.58M +71.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-04
2016 $5.02M -$2.85M -36.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $7.88M -$2.76M -26% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $10.6M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.